These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 21291526

  • 1. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.
    Jiang M, Liu Z, Xiang Y, Ma H, Liu S, Liu Y, Zheng D.
    BMC Cancer; 2011 Feb 03; 11():54. PubMed ID: 21291526
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
    Wang Y, He L, He G, Kong Y, Liu X, Cai H, Liu X, Tan W.
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun 03; 26(6):780-8. PubMed ID: 20815258
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma.
    Kondo K, Yamasaki S, Sugie T, Teratani N, Kan T, Imamura M, Shimada Y.
    Int J Cancer; 2006 Jan 01; 118(1):230-42. PubMed ID: 16003725
    [Abstract] [Full Text] [Related]

  • 6. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z, Khan AA, Prasad GB, Khan N, Tiwari RP, Bisen PS.
    Radiother Oncol; 2016 Feb 01; 118(2):359-68. PubMed ID: 26747757
    [Abstract] [Full Text] [Related]

  • 7. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma.
    Kaliyaperumal K, Sharma AK, McDonald DG, Dhindsa JS, Yount C, Singh AK, Won JS, Singh I.
    Redox Biol; 2015 Dec 01; 6():41-50. PubMed ID: 26177470
    [Abstract] [Full Text] [Related]

  • 8. E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma.
    Adhim Z, Lin X, Huang W, Morishita N, Nakamura T, Yasui H, Otsuki N, Shigemura K, Fujisawa M, Nibu K, Shirakawa T.
    Cancer Gene Ther; 2012 Feb 01; 19(2):144-52. PubMed ID: 22116375
    [Abstract] [Full Text] [Related]

  • 9. Adeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude mice.
    Zheng L, Weilun Z, Minghong J, Yaxi Z, Shilian L, Yanxin L, Dexian Z.
    BMC Cancer; 2012 Apr 24; 12():153. PubMed ID: 22530952
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.
    Zhang X, Cheung RM, Komaki R, Fang B, Chang JY.
    Clin Cancer Res; 2005 Sep 15; 11(18):6657-68. PubMed ID: 16166445
    [Abstract] [Full Text] [Related]

  • 13. The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer.
    Li D, Day KV, Yu S, Shi G, Liu S, Guo M, Xu Y, Sreedharan S, O'Malley BW.
    Cancer Res; 2002 Aug 15; 62(16):4637-44. PubMed ID: 12183420
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prospective antitumor effects of the combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin against esophageal squamous cell carcinoma.
    Kondo K, Yamasaki S, Inoue N, Sugie T, Teratani N, Kan T, Shimada Y.
    Surg Today; 2006 Aug 15; 36(11):966-74. PubMed ID: 17072716
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models.
    Sobral LM, Sousa LO, Coletta RD, Cabral H, Greene LJ, Tajara EH, Gutkind JS, Curti C, Leopoldino AM.
    Mol Cancer; 2014 Feb 20; 13():32. PubMed ID: 24555657
    [Abstract] [Full Text] [Related]

  • 20. Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide.
    Hingtgen S, Ren X, Terwilliger E, Classon M, Weissleder R, Shah K.
    Mol Cancer Ther; 2008 Nov 20; 7(11):3575-85. PubMed ID: 19001440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.